A sterile suspension for treatment of subclinical mastitis in dairy cattle at the time of dry off associated with strains of staphylococcus and streptococcus.
Ingredients: Each 10 mL syringe contains 500 mg Ceftiofur Equivalents (as the hydrochloride salt), 700 mg microcrystalline wax, 500 mg labrafil M 1944 CS, and cottonseed oil q.s.
Dosage and Administration: Consult your veterinarian.
Storage: Store at controlled room temperature 20 to 25 C (68 to 77 F). Protect from light. Store plastets in carton until used.
Caution: Milk taken from cows completing a 30-day dry cow period may be used for food with no milk discard due to ceftiofur residues.
Following label use, no pre-slaughter withdrawal period is required for neonatal calves born from treated cows regardless of colostrum consumption.
Following intramammary infusion, a 16-day pre-slaughter withdrawal period is required for treated cows.
Use of this product in a manner other than indicated under DOSAGE might result in violative residues.
